Lavinia Patricia Mocan, Cristiana Grapa, Rareș Crăciun, Ioana Ecaterina Pralea, Alina Uifălean, Andreea Maria Soporan, Ximena Maria Mureșan, Maria Iacobescu, Nadim Al Hajjar, Carmen Mihaela Mihu, Zeno Spârchez, Tudor Mocan, Cristina Adela Iuga
Recent advancements in proteomics have shown promise in identifying biomarkers for various cancers. Our study is the first to compare the serum proteomes of intrahepatic cholangiocarcinoma (iCCA) with cirrhosis (CIR), primary sclerosing cholangitis (PSC), and hepatocellular carcinoma (HCC), aiming to identify a proteomic signature that can effectively distinguish among these conditions. Utilizing high-throughput mass spectrometry on serum samples, we identified 845 proteins, of which 646 were suitable for further analysis...
2024: Frontiers in Pharmacology